Related references
Note: Only part of the references are listed.Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study
Osnat Bairey et al.
ANNALS OF HEMATOLOGY (2011)
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2
Angela Schulz et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Prognosis of Binet stage A chronic lymphocytic leukemia patients: the strength of routine parameters
Remi Letestu et al.
BLOOD (2010)
Age at Diagnosis and the Utility of Prognostic Testing in Patients With Chronic Lymphocytic Leukemia
Tait D. Shanafelt et al.
CANCER (2010)
Senescent cells as a source of inflammatory factors for tumor progression
Albert R. Davalos et al.
CANCER AND METASTASIS REVIEWS (2010)
Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and β2-microglobulin in B-cell chronic lymphocytic leukemia
Stefano Molica et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M. Hallek et al.
LANCET (2010)
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Jan A. Burger et al.
BLOOD (2009)
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
Antonina V. Kurtova et al.
BLOOD (2009)
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate
Julio Delgado et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Adipose Tissue: The New Endocrine Organ? A Review Article
Susan E. Wozniak et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Predictive value of β2-microglobulin levels in Binet A stage chronic lymphocytic leukemia
Massimo Gentile et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Characteristics Associated With Important Clinical End Points in Patients With Chronic Lymphocytic Leukemia at Initial Treatment
William G. Wierda et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles
M. Plander et al.
LEUKEMIA (2009)
High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort
M. D. Seftel et al.
LEUKEMIA RESEARCH (2009)
Telomere length measurement by a novel monochrome multiplex quantitative PCR method
Richard M. Cawthon
NUCLEIC ACIDS RESEARCH (2009)
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
Laura Z. Rassenti et al.
BLOOD (2008)
The immunodeficiency of chronic lymphocytic leukaemia
A. D. Hamblin et al.
BRITISH MEDICAL BULLETIN (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
William G. Wierda et al.
BLOOD (2007)
Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors
J Campisi
CELL (2005)
Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia
JB Johnston et al.
ONCOGENE (2003)
Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people
H Bruunsgaard et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia
WG Wierda et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia
R Lai et al.
CANCER (2002)
Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells
A Moreno et al.
BLOOD (2001)
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome
L Fayad et al.
BLOOD (2001)
Share Paper
